Haytaian Peter D's Form 4 filing
Elevance Health, Inc. (ELV) · filed Mar 14, 2022
- Accession no.
- 0001156039-22-000040
- Filed
- Mar 14, 2022
- Trade date
- Mar 10, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.16M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Haytaian Peter DCIK 0001608538 | Officer (EVP & Pres., DBG & IngenioRx) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseAcquired | +1,848 | $131.80 | +$243,566.4 | 29,864 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −2,170 | $458.68F2 | −$995,335.6 | 27,694 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −4,274 | $459.75F3 | −$1,964,971.5 | 23,420 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −4,105 | $460.68F4 | −$1,891,091.4 | 19,315 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −5,874 | $461.72F5 | −$2,712,143.28 | 13,441 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −1,240 | $462.73F6 | −$573,785.2 | 12,201 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −40 | $463.40 | −$18,536 | 12,161 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseDisposed | −1,848 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $458.18 to $459.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $459.25 to $460.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $460.26 to $461.19. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $461.27 to $462.26. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $462.34 to $463.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.